当前位置: X-MOL 学术Lancet Respir. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Raising standards in the delivery of acute NIV
The Lancet Respiratory Medicine ( IF 38.7 ) Pub Date : 2017-09-19 , DOI: 10.1016/s2213-2600(17)30335-1
The Lancet Respiratory Medicine

Non-invasive ventilation (NIV) is now widely used in the hospital setting for not only exacerbations of chronic obstructive pulmonary disease (COPD) but also other causes of acute respiratory failure (ARF). As NIV has become more readily available and the scope of use widened, ongoing assessment of the safety and quality of care provided to patients is vital. On Aug 31, 2017, the European Respiratory Society and American Thoracic Society published recommendations for the clinical application of NIV.

中文翻译:

提高急性 NIV 的实施标准

无创通气 (NIV) 目前在医院环境中广泛使用,不仅用于治疗慢性阻塞性肺病 (COPD) 的恶化,还用于治疗其他原因引起的急性呼吸衰竭 (ARF)。随着 NIV 变得更加容易获得并且使用范围扩大,对为患者提供的护理的安全性和质量进行持续评估至关重要。 2017年8月31日,欧洲呼吸学会和美国胸科学会发布了NIV临床应用建议。
更新日期:2017-09-19
down
wechat
bug